MDM2 and glioblastoma: Because the inhibition of PI3K/AKT/mTOR signalling can augment p53-mediated apoptosis29, AKT/mTOR may synergize with inhibitors of the MDM2/p53 complex to promote anti-tumoural activity in GBM cells that retain p53 function.